Research graph
References from A State‐Resolved Single‐Cell and Spatial Atlas Reveals <i>IDH</i> ‐Associated Differences in Malignant and Immune Architecture in Diffuse Glioma. Local targets link to admitted publications; unresolved targets remain external evidence.
The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary
10.1093/neuonc/noab106 · 2021 · External reference
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long‐Term Outcomes
10.3390/cancers17010146 · 2025 · External reference
Diffuse Glioma Heterogeneity and Its Therapeutic Implications
10.1158/2159-8290.cd-20-1474 · 2021 · External reference
New Insights Into the Immune TME of Adult‐Type Diffuse Gliomas
10.1097/wco.0000000000001112 · 2022 · External reference
Single‐Cell RNA‐seq Highlights Intratumoral Heterogeneity in Primary Glioblastoma
10.1126/science.1254257 · 2014 · External reference
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
10.1016/j.cell.2019.06.024 · 2019 · External reference
Decoupling Genetics, Lineages, and Microenvironment in IDH‐Mutant Gliomas by Single‐Cell RNA‐seq
10.1126/science.aai8478 · 2017 · External reference
Single‐Cell RNA‐seq Supports a Developmental Hierarchy in human Oligodendroglioma
10.1038/nature20123 · 2016 · External reference
Glioma Progression Is Shaped by Genetic Evolution and Microenvironment Interactions
2022 · External reference
Isocitrate Dehydrogenase Mutations Suppress STAT1 and CD8+ T Cell Accumulation in Gliomas
10.1172/jci90644 · 2017 · External reference
Hypoxia Coordinates the Spatial Landscape of Myeloid Cells Within Glioblastoma to Affect Survival
10.1126/sciadv.adj3301 · 2024 · External reference
Spatial Transcriptomics Reveals Segregation of Tumor Cell States in Glioblastoma and Marked Immunosuppression Within the Perinecrotic Niche
10.1186/s40478-024-01769-0 · 2024 · External reference
10.1101/2024.06.13.598923
10.1101/2024.06.13.598923 · External reference
SURG‐23. Establishment of an Appropriate Glioma Surgery System Considering Molecular and Functional Boundaries [abstract]
10.1093/neuonc/noae165.1103 · 2024 · External reference
Unveiling the Inflammatory Landscape of Recurrent Glioblastoma Through Histological‐Based Assessments
10.3390/cancers16193283 · 2024 · External reference
Systematic Assessment of Tissue Dissociation and Storage Biases in Single‐Cell and Single‐Nucleus RNA‐seq Workflows
10.1186/s13059-020-02048-6 · 2020 · External reference
Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell‐Cycle Arrest
10.1016/j.stemcr.2015.09.014 · 2015 · External reference
Comparative Single‐cell RNA‐Sequencing Profiling of BMP4‐Treated Primary Glioma Cultures Reveals Therapeutic Markers
10.1093/neuonc/noac143 · 2022 · External reference
Glioma Stem Cells Are More Aggressive in Recurrent Tumors With Malignant Progression Than in the Primary Tumor, and Both Can be Maintained Long‐Term in Vitro
10.1186/1471-2407-8-304 · 2008 · External reference
Glioblastoma scRNA‐seq Shows Treatment‐Induced, Immune‐Dependent Increase in Mesenchymal Cancer Cells and Structural Variants in Distal Neural Stem Cells
10.1093/neuonc/noac085 · 2022 · External reference
Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
10.3390/cancers14051176 · 2022 · External reference
A DNA Repair and Cell‐Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications
10.1158/0008-5472.can-18-2076 · 2019 · External reference
Stalled Oligodendrocyte Differentiation in IDH‐Mutant Gliomas
10.1186/s13073-023-01175-6 · 2023 · External reference
Distinct Aneuploid Evolution of Astrocytoma and Glioblastoma During Recurrence
2023 · External reference
Single‐Cell Omics in Dissecting Immune Microenvironment of Malignant Gliomas: Challenges and Perspectives
10.3390/cells10092264 · 2021 · External reference
Comparison of Tumor Immune Environment Between Newly Diagnosed and Recurrent Glioblastoma Including Matched Patients
10.1007/s11060-022-04053-0 · 2022 · External reference
Heterogeneity Matters: Different Regions of Glioblastoma Are Characterized by Distinctive Tumor‐Supporting Pathways
10.3390/cancers12102960 · 2020 · External reference
Astrogliosis Releases Pro‐Oncogenic Chitinase 3‐Like 1 Causing MAPK Signaling in Glioblastoma
10.3390/cancers11101437 · 2019 · External reference
Interferon‐stimulated Gene 15 (ISG15) Is a Trigger for Tumorigenesis and Metastasis of Hepatocellular Carcinoma
10.18632/oncotarget.2316 · 2014 · External reference
The CLDN5 Gene at the Blood‐Brain Barrier in Health and Disease
10.1186/s12987-023-00424-5 · 2023 · External reference
Regulator of G‐Protein Signaling 5 (RGS5) Protein: A Novel Marker of Cancer Vasculature Elicited and Sustained by the Tumor's Proangiogenic Microenvironment
10.1007/s00018-011-0862-8 · 2012 · External reference
DNA Methylation and Gene Expression of COX7A1, SPINT1 and KRT81 in Glioblastoma and Brain Tissue
10.6001/biologija.v58i2.2488 · 2012 · External reference
Systems Genetic Analysis of Osteoblast‐Lineage Cells
10.1371/journal.pgen.1003150 · 2012 · External reference
IDH Mutant Gliomas Escape Natural Killer Cell Immune Surveillance by Downregulation of NKG2D Ligand Expression
10.1093/neuonc/now061 · 2016 · External reference
PD‐1 Inhibitors: Do They Have a Future in the Treatment of Glioblastoma?
10.1158/1078-0432.ccr-20-1135 · 2020 · External reference
Dual Role of ARPC1B in Regulating the Network Between Tumor‐Associated Macrophages and Tumor Cells in Glioblastoma
10.1080/2162402x.2022.2031499 · 2022 · External reference
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
10.3390/cancers12102973 · 2020 · External reference
Identification of Astrocytoma Blood Serum Protein Profile
10.3390/cells9010016 · 2019 · External reference
Comparative Insight Into Microglia/Macrophages‐Associated Pathways in Glioblastoma and Alzheimer's Disease
10.3390/ijms25010016 · 2023 · External reference
Long Noncoding RNA Pvt1 Regulates the Immunosuppression Activity of Granulocytic Myeloid‐Derived Suppressor Cells in Tumor‐Bearing Mice
10.1186/s12943-019-0978-2 · 2019 · External reference
A Virus‐Mimicking Nucleic Acid Nanogel Reprograms Microglia and Macrophages for Glioblastoma Therapy
10.1002/adma.202006116 · 2021 · External reference
Immune Involvement of the Contralateral Hemisphere in a Glioblastoma Mouse Model
10.1136/jitc-2019-000323 · 2020 · External reference
Inhibition of Arginase by CB‐1158 Blocks Myeloid Cell‐Mediated Immune Suppression in the Tumor Microenvironment
10.1186/s40425-017-0308-4 · 2017 · External reference
Metabolic State of Glioma Stem Cells and Nontumorigenic Cells
10.1073/pnas.1106704108 · 2011 · External reference
GAP43‐Dependent Mitochondria Transfer From Astrocytes Enhances Glioblastoma Tumorigenicity
10.1038/s43018-023-00556-5 · 2023 · External reference
Targeting Cellular Respiration as a Therapeutic Strategy in Glioblastoma
10.18632/oncotarget.28424 · 2023 · External reference
Hypoxia Within the Glioblastoma Tumor Microenvironment: A Master Saboteur of Novel Treatments
10.3389/fimmu.2024.1384249 · 2024 · External reference
The Role of Hypoxia in Glioblastoma Invasion
10.3390/cells6040045 · 2017 · External reference
Metabolic Reprogramming in Glioblastoma: The Influence of Cancer Metabolism on Epigenetics and Unanswered Questions
10.1093/neuonc/nov125 · 2016 · External reference
SPOTlight: Seeded NMF Regression to Deconvolute Spatial Transcriptomics Spots With Single‐Cell Transcriptomes
10.1093/nar/gkab043 · 2021 · External reference
Suppression of Antitumor T Cell Immunity by the Oncometabolite (R)‐2‐Hydroxyglutarate
10.1038/s41591-018-0095-6 · 2018 · External reference
Integrative Spatial Analysis Reveals a Multi‐Layered Organization of Glioblastoma
10.1016/j.cell.2024.03.029 · 2024 · External reference
